Development of a chemotherapeutic injectable formulation of enhanced activity containing a novel anticancer drug in a self-associated nanosystem.
Project ID: 2024-1.2.1-HE_PARTNERSÉG-2025-00036 Duration: From 01.05.2025 to 30.04.2028. Role of Cyclolab: partner organization Press release Sajtóközlemény
FLAVIVIRUS Mechanism and in vivo activity of novel glycan-based therapy against flavivirus endothelial permeability and vascular leak Evaluation of therapeutics targeting SARS-CoV-2 infection and defining pathogenic mechanisms of SARS-CoV-2-triggered pulmonary dysfunction NIAID/NIH R21 AI146464 Duration: 2020-2022 Role of Cyclolab: partner organization